Biomerica (BMRA) Director Eric Chin Buys 6,250 Shares

What Happened Eric Chin, a director of Biomerica, acquired 6,250 shares of the company’s common stock on August 26, 2026 at $1.60 per share in a private placement, for a total cash outlay of $10,000. This was a purchase (code P) reported on a Form 4 filed on August 27, 2026.

Key Details

• Transaction date: August 26, 2026; filing date: August 27, 2026 (timely).
• Shares purchased: 6,250 at $1.60 / share — total $10,000.
• Shares owned after transaction: Not disclosed in the provided filing details.
• Transaction type/code: Private placement purchase (P).
• Footnote: Acquisition was via a private placement under a Securities Purchase Agreement dated August 20, 2026, involving institutional and individual investors (including B. Riley Principal Capital, LLC and certain company directors and officers).

Context This was a direct purchase in a private placement rather than an open-market buy or option exercise. Purchases by insiders can be taken as a direct investment signal, but this summary is factual only — it does not speculate on motivations or future company performance.